VISEN Pharmaceuticals (HKG:2561)
24.62
-0.28 (-1.12%)
Apr 24, 2026, 3:59 PM HKT
VISEN Pharmaceuticals Market Cap
VISEN Pharmaceuticals has a market cap or net worth of 2.71 billion as of April 24, 2026. Its market cap has decreased by -51.16% in one year.
Market Cap
2.71B
Enterprise Value
2.21B
Revenue
151.34K
Ranking
n/a
PE Ratio
n/a
Stock Price
24.62
Market Cap Chart
Since March 21, 2025, VISEN Pharmaceuticals's market cap has decreased from 7.20B to 2.71B, a decrease of -62.27%. That is a compound annual growth rate of -59.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 2.68B | -22.07% |
| Dec 31, 2025 | 3.44B | -52.13% |
| Mar 21, 2025 | 7.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SSY Group | 6.93B |
| Edding Genor Group Holdings | 6.88B |
| Beijing Tong Ren Tang Chinese Medicine Company | 6.38B |
| Hua Medicine (Shanghai) | 3.49B |
| Golden Throat Holdings Group Company | 2.65B |
| Jacobson Pharma Corporation | 2.28B |
| JBM (Healthcare) | 2.08B |
| Essex Bio-Technology | 1.87B |